Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Buy
180,647
+50,000
+38% +$276K ﹤0.01% 2332
2026
Q1
$724K Buy
+130,647
New +$735K ﹤0.01% 2448
2025
Q3
Sell
-93,500
Closed -$224K 2287
2025
Q2
$224K Buy
93,500
+14,643
+19% +$29.4K ﹤0.01% 2553
2025
Q1
$152K Buy
78,857
+29,795
+61% +$99.2K ﹤0.01% 2585
2024
Q4
$252K Buy
+49,062
New +$302K ﹤0.01% 2623
2022
Q2
Sell
-19,529
Closed -$53.3K 2692
2022
Q1
$53.3K Buy
+19,529
New +$120K ﹤0.01% 2763

Other funds holding ANNX

UBS AM's ANNX Position: Q2 2026 in Review

UBS AM increased its Annexon (ANNX) stake by 38% in Q2 2026, buying an estimated $276K and bringing the position to 180,647 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #2332.

UBS AM first reported a position in ANNX in Q1 2022 and has held it in 6 quarters since. 216 funds tracked by Wall St. Rank hold ANNX as of Q2 2026.

  • UBS AM held 180,647 shares of Annexon worth $1.03M as of Q2 2026.
  • UBS AM bought 50,000 Annexon shares in Q2 2026, an estimated $276K.
  • Annexon made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2332 holding.
  • UBS AM first reported a position in Annexon in Q1 2022 and has held it in 6 quarters since.
  • 216 funds tracked by Wall St. Rank held Annexon as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.